Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (15 quarters reported)
$105M in Q4 2022 → $176M now. Hover for any quarter.
As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Aclaris Therapeutics Inc | 36.0% | Trimmed 16% | 11,975,000 | $63.3M |
| Atea Pharmaceuticals Inc | 18.4% | Trimmed 1.5% | 6,952,330 | $32.3M |
| Engene Therapeutics Inc | 6.6% | New | 6,669,908 | $11.5M |
| Kraft Heinz Co | 6.2% | Added 272% | 465,000 | $11M |
| OM Outset Med Inc | 6.2% | Added 32% | 2,519,701 | $10.9M |
| Carmax Inc | 5.2% | Added 11% | 172,500 | $9.12M |
| Tillys Inc | 5.1% | Unchanged | 2,150,000 | $9.03M |
| Pmv Pharmaceuticals Inc | 4.1% | Added 0.2% | 5,330,000 | $7.14M |
| Instil Bio Inc | 2.8% | Unchanged | 645,600 | $4.96M |
| Target Corp | 2.8% | Unchanged | 37,500 | $4.9M |
| Oramed Pharmaceuticals Inc | 2.4% | Trimmed 73% | 866,269 | $4.17M |
| Janux Therapeutics Inc | 1.4% | Unchanged | 154,961 | $2.38M |
| Pliant Therapeutics Inc | 1.0% | Unchanged | 1,546,137 | $1.76M |
| CB Connect Biopharma Hldgs Ltd | 0.8% | Added 40% | 573,287 | $1.36M |
| Imagenebio Inc | 0.7% | Unchanged | 200,730 | $1.18M |
| Walmart Inc Put | 0.2% | Unchanged | 335 | $386K |
| CS Core Scientific Inc New Put | 0.2% | New | 800 | $298K |
| Tesla Inc Put | 0.2% | New | 375 | $270K |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended June 30, 2026 · filed August 07, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Aclaris Therapeutics Inc | Trimmed | −2,275,000 | −$12M | 36.0% |
| Engene Therapeutics Inc | New | +6,669,908 | +$11.5M | 6.6% |
| Oramed Pharmaceuticals Inc | Trimmed | −2,300,962 | −$11.1M | 2.4% |
| Kraft Heinz Co | Added | +340,000 | +$8.03M | 6.2% |
| Kezar Life Sciences Inc | Exited | −720,787 | −$5.35M | — |
| OM Outset Med Inc | Added | +617,500 | +$2.67M | 6.2% |
| Carmax Inc | Added | +17,500 | +$926K | 5.2% |
| Atea Pharmaceuticals Inc | Trimmed | −106,327 | −$494K | 18.4% |
| CB Connect Biopharma Hldgs Ltd | Added | +164,400 | +$391K | 0.8% |
| CS Core Scientific Inc New | New | +800 | +$298K | 0.2% |
Showing the 10 largest of 12 changes.
quarter ended March 31, 2026 · filed May 06, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Tillys Inc | New | +2,150,000 | +$8.71M | 5.6% |
| OM Outset Med Inc | Added | +1,359,021 | +$5.22M | 4.7% |
| Kraft Heinz Co | New | +125,000 | +$2.81M | 1.8% |
| Atea Pharmaceuticals Inc | Trimmed | −431,343 | −$2.32M | 24.4% |
| Janux Therapeutics Inc | New | +154,961 | +$2.15M | 1.4% |
| Carvana Co | Exited | −150 | −$2.02M | — |
| Tesla Inc | Exited | −1,000 | −$205K | — |
| Lisata Therapeutics Inc | Exited | −73,348 | −$136K | — |
| Imagenebio Inc | Added | +23,704 | +$119K | 0.6% |
| Pmv Pharmaceuticals Inc | Added | +28,000 | +$34.7K | 4.2% |
quarter ended December 31, 2025 · filed February 03, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Adverum Biotechnologies Inc | Exited | −3,057,526 | −$13.9M | — |
| Carmax Inc | New | +155,000 | +$5.99M | 5.2% |
| Alumis Inc | Exited | −1,210,415 | −$4.83M | — |
| Lava Therapeutics Nv | Exited | −1,970,610 | −$3.07M | — |
| Target Corp | Added | +27,500 | +$2.69M | 3.2% |
| CB Connect Biopharma Hldgs Ltd | Trimmed | −858,613 | −$2.42M | 1.0% |
| Carvana Co | New | +150 | +$2.02M | 1.7% |
| OM Outset Med Inc | New | +543,180 | +$2.02M | 1.7% |
| Pliant Therapeutics Inc | New | +1,546,137 | +$1.89M | 1.6% |
| AP Athira Pharma Inc | Exited | −323,066 | −$1.34M | — |
Showing the 10 largest of 20 changes.
quarter ended September 30, 2025 · filed November 10, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Essa Pharma Inc | Exited | −4,221,546 | −$7.18M | — |
| IO Ikena Oncology Inc | Exited | −4,030,102 | −$5.4M | — |
| MP Milestone Pharmaceuticals In | Exited | −1,136,091 | −$2.2M | — |
| Elevation Oncology Inc | Exited | −5,890,434 | −$2.16M | — |
| Instil Bio Inc | Added | +110,701 | +$1.98M | 10.6% |
| CB Connect Biopharma Hldgs Ltd | New | +1,267,500 | +$1.91M | 1.8% |
| CB Connect Biopharma Hldgs Ltd | Exited | −1,821,558 | −$1.79M | — |
| Tesla Inc | Exited | −200 | −$1.65M | — |
| Imagenebio Inc | New | +182,509 | +$1.49M | 1.4% |
| AP Athira Pharma Inc | New | +323,066 | +$1.34M | 1.2% |
Showing the 10 largest of 24 changes.
quarter ended June 30, 2025 · filed August 11, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| An2 Therapeutics Inc | Exited | −5,749,432 | −$7.82M | — |
| Alumis Inc | Added | +1,160,788 | +$3.48M | 2.7% |
| Whitehawk Therapeutics Inc | Exited | −1,890,245 | −$3.36M | — |
| Instil Bio Inc | Added | +118,179 | +$2.46M | 8.4% |
| Tesla Inc | New | +200 | +$1.65M | 1.3% |
| Pmv Pharmaceuticals Inc | Added | +1,252,388 | +$1.33M | 4.0% |
| Sage Therapeutics Inc | Exited | −135,095 | −$1.07M | — |
| Kezar Life Sciences Inc | Added | +227,045 | +$1.04M | 2.2% |
| Adverum Biotechnologies Inc | Added | +315,209 | +$678K | 5.0% |
| Corvus Pharmaceuticals Inc | New | +118,766 | +$475K | 0.4% |
Showing the 10 largest of 20 changes.
quarter ended March 31, 2025 · filed May 07, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IT Ishares Tr | Exited | −260,000 | −$26.1M | — |
| Third Harmonic Bio Inc | New | +3,824,417 | +$13.3M | 10.7% |
| Lava Therapeutics Nv | New | +1,960,610 | +$2.49M | 2.0% |
| Adverum Biotechnologies Inc | Added | +474,253 | +$2.07M | 9.7% |
| Kezar Life Sciences Inc | Added | +359,470 | +$1.75M | 1.6% |
| Elevation Oncology Inc | New | +5,890,934 | +$1.53M | 1.2% |
| Sage Therapeutics Inc | New | +135,095 | +$1.07M | 0.9% |
| Oramed Pharmaceuticals Inc | Added | +376,841 | +$806K | 5.2% |
| PT Palvella Therapeutics Inc Ne | Exited | −42,130 | −$506K | — |
| Turnstone Biologics Corp | New | +1,103,386 | +$452K | 0.4% |
Showing the 10 largest of 21 changes.
quarter ended December 31, 2024 · filed February 07, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SS SPDR Ser Tr | Exited | −175,000 | −$16.1M | — |
| Essa Pharma Inc | New | +4,221,546 | +$7.56M | 4.7% |
| Tectonic Therapeutic Inc | Exited | −211,752 | −$6.42M | — |
| RP Reneo Pharmaceuticals Inc | Exited | −3,457,395 | −$5.88M | — |
| IO Ikena Oncology Inc | Added | +2,862,578 | +$4.69M | 3.7% |
| Atea Pharmaceuticals Inc | Added | +958,312 | +$3.21M | 15.8% |
| Pmv Pharmaceuticals Inc | Added | +1,777,912 | +$2.68M | 3.3% |
| AP Athira Pharma Inc | New | +2,775,885 | +$1.63M | 1.0% |
| Lenz Therapeutics Inc | Trimmed | −50,729 | −$1.46M | 0.2% |
| Instil Bio Inc | Added | +65,000 | +$1.24M | 4.7% |
Showing the 10 largest of 24 changes.
quarter ended September 30, 2024 · filed November 05, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Tectonic Therapeutic Inc | Trimmed | −254,295 | −$7.71M | 3.8% |
| An2 Therapeutics Inc | New | +5,749,432 | +$6.15M | 3.6% |
| AB Aadi Bioscience Inc | New | +2,000,000 | +$4.12M | 2.4% |
| Instil Bio Inc | Trimmed | −56,103 | −$3.78M | 13.3% |
| Wingstop Inc | Exited | −714 | −$3.58M | — |
| Achilles Therapeutics PLC | Added | +3,474,828 | +$3.54M | 2.5% |
| AP Athira Pharma Inc | Exited | −900,000 | −$2.39M | — |
| SS SPDR Ser Tr | Trimmed | −25,000 | −$2.3M | 9.5% |
| Adverum Biotechnologies Inc | Added | +302,064 | +$2.12M | 9.4% |
| Oramed Pharmaceuticals Inc | Added | +837,153 | +$2.04M | 3.1% |
Showing the 10 largest of 26 changes.
Loading...
